auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Applied Pharmaceutical InnovationAmount
$21.9M
Province
ABType
Contribution
Agreement Number
033-2025-2026-Q4-515742
Purpose
API intends to perform the end to end manufacturing of antimicrobial drug products as a demonstration of domestic medicine manufacturing capabilities.
Applied Pharmaceutical Innovation × Innovation, Science and Economic Development Canada
1 grants totalling $21.9M
Life Sciences Fund Contributions
7 grants totalling $140.3M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Canadian Blood Services | $75.0M | Life Sciences Fund Contributions |
| Qidni Labs Inc. | $12.5M | Life Sciences Fund Contributions |
| Avivo Biomedical Inc | $11.0M | Life Sciences Fund Contributions |
| Avivo Biomedical Inc | $11.0M | Life Sciences Fund Contributions |
| Northern RNA Inc. | $6.0M | Life Sciences Fund Contributions |